Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells

The present studies were designed to determine whether the multi-kinase inhibitor sorafenib (Nexavar) interacted with histone deacetylase inhibitors to kill glioblastoma and medulloblastoma cells. In a dose-dependent fashion sorafenib lethality was enhanced in multiple genetically disparate primary...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Tang, Yong, Yacoub, Adly, Hamed, Hossein A., Poklepovic, Andrew, Tye, Gary W., Grant, Steven, Dent, Paul
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Landes Bioscience 2012
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3679096/
https://ncbi.nlm.nih.gov/pubmed/22406992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/cbt.19771
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia